According to Recursion Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is $65.73 Million USD. In 2025 the company made a revenue of $74.25 Million USD an increase over the revenue in the year 2024 that were of $58.48 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.